True Data Inc.

Business Details

The company refines and standardizes ID-POS data collected from drugstores, supermarkets, and other retailers nationwide, covering approximately 60 million individuals and an annual transaction value of approximately ¥5.5 trillion, and provides it as SaaS solutions for consumer goods manufacturers (Eagle Eye, etc.), for retailers (Shopping Scan, etc.), and for all industries. The ability to provide data, technology, and utilization know-how in an integrated manner differentiates the company from competitors. The business is based on a monthly subscription-based recurring revenue model, with a structure in which profitability improves at an accelerating pace as sales expand.

Recent Overview

In FY2026 (ending March 2026), the company achieved a significant increase in both sales and profit, with net sales up 20.3% and operating profit up 109.6%

In FY2026 (ending March 2026), the company achieved net sales of ¥1,870 million (up 20.3% year on year), operating profit of ¥101 million (up 109.6% year on year), and net income of ¥80 million (up 508.5% year on year), representing substantial growth in both sales and profit. This was driven by the accumulation of contracted companies for the core Eagle Eye service and the vertical expansion of retail DX services and AI solutions for major retailers. The launch of a collaboration with Alfresa Healthcare and a strategic business alliance with ARATA CORPORATION completed a network of wholesale trading company collaboration partners covering the three main areas of food, pharmaceuticals, and daily necessities. The company also obtained ISO/IEC 27001:2022 certification. On the other hand, full-year results fell short of the initial forecast due to increased upfront costs associated with human capital investment and the refinement of AI solution operations. For FY2027 (ending March 2027), the company expects net sales of ¥2,200 million (up 17.6% year on year), while forecasting a decline in operating profit to ¥80 million (down 21.3% year on year) reflecting planned strategic investment expenses.

Key Products

Growth Drivers

• Quantitative expansion of the recurring revenue base through the accumulation of contracted companies for the core SaaS offering Eagle Eye
• Increased customer spend through vertical expansion (cross-selling) of retail DX services and AI solutions for major retailers
• Expansion of sales channels into the three areas of food, pharmaceuticals, and daily necessities through the completed network of collaboration partners with ITOCHU Corporation, Alfresa Healthcare, and ARATA CORPORATION
• Horizontal expansion into the retail media domain through the linkage of purchasing segment data for advertising with SMN Corporation and MBK Digital
• Development of high-value-added solutions combining retail data and AI insights through strengthened partnerships with AI startups
• Evolution into a "decision-support company" and horizontal deployment of standardized data utilization infrastructure under the new medium-term management plan (FY2027 (ending March 2027) to FY2029 (ending March 2029))
• Medium- to long-term market expansion driven by the megatrends of big data utilization, corporate DX, and AI

Risks

• Risk that profit growth will be limited by increased upfront costs associated with human capital investment and the refinement of AI solution operations (operating profit is forecast to decline 21.3% in FY2027 (ending March 2027) despite higher sales)
• Information security and data governance risks stemming from a business model that handles personal information and ID-POS data (response being strengthened through ISO/IEC 27001:2022 certification)
• Risk of transaction termination due to policy changes or M&A on the retailer side, given that purchasing data linkage with retailers forms the foundation of the business (there is a past instance of transaction termination with a major convenience store chain)
• Risk of delayed profitability improvement, given accumulated deficit of retained earnings of △¥419 million (although improved from △¥499 million in the prior period, the balance remains in deficit)
• Risk that customer acquisition costs will remain elevated due to limited brand recognition
• Risk that macroeconomic uncertainties such as US trade policy trends, yen depreciation, and the slowdown of the Chinese economy will affect the investment appetite of client companies